Coherus Oncology Inc.
CHRS | NASDAQ
$1.33
-$0.04 (-2.92%)
Sep 22, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -58.96M | -37.94M | 241.2M | -35.53M | 297.77M | -56.57M | -50.7M | -10.75M | -54.85M | 102.88M | -79.65M | -39.64M | -42.87M | -75.73M | -58.87M | -86.65M | -50.15M | -96.08M | -45.73M | -38.53M | -29.9M | -172.95M |
Depreciation & Amortization | 1.74M | 881K | 2.06M | 966K | 1.02M | 1.05M | 1.03M | 1.55M | 1.19M | 1.51M | 1.06M | 899K | 880K | 949K | 1.05M | 995K | 887K | 767K | 1.43M | 892K | 877K | 849K |
Stock-Based Compensation | 4.97M | 2.39M | 10.79M | 3.39M | 5.42M | 5.37M | 6.38M | 6.87M | n/a | 7.32M | 10.8M | 9.95M | 10.08M | 12.28M | 11.73M | 12.28M | 13.85M | 12.88M | n/a | 11.94M | 11.6M | 16.88M |
Other Working Capital | -53.72M | -10.65M | -101.31M | 7.7M | -70.48M | -30.83M | -1.68M | -12.04M | -34.73M | -9.12M | 63M | 60.12M | 40.65M | -26.94M | -27.63M | 15.1M | -2.98M | -24.9M | 4.86M | -11.23M | 19.14M | 904K |
Other Non-Cash Items | -11.33M | 468K | -260.98M | -5.77M | -327.18M | 13.47M | 17.35M | 1.85M | 39.13M | -147.09M | 48.49M | 1.24M | -774K | 3.11M | 754K | 27.59M | 1.6M | 45.51M | 12.59M | 7.09M | -7.02M | 150.19M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 874K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -56.4M | -23.68M | -12.79M | -9.39M | -23.65M | 10.86M | 54.54M | -61.53M | 74.26M | -11.38M | 6.37M | -27.62M | -6.23M | -9.35M | -54.61M | 8.69M | -16.22M | -17.12M | -20.61M | 32.32M | 24.26M | 6.39M |
Operating Cash Flow | -119.98M | -57.89M | -19.72M | -46.34M | -46.63M | -25.83M | 28.61M | -62.02M | 59.73M | -46.77M | -12.94M | -54.3M | -38.92M | -68.73M | -99.95M | -37.09M | -50.04M | -54.05M | -52.32M | 13.71M | -188K | 1.37M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -34K | n/a | -100K | -152K | -87K | -457K | -880K | -615K | -468K | -261K | -415K | -145K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 76K | 151K | 440K | 178K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -20.29M | -6.39M | -14.26M | -68.85M | -20.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.51M | -178K | -127.38M | n/a | n/a | n/a | -10.71M | -31.45M | n/a | -140.33M |
Sales Maturities Of Investments | 81.67M | 38.14M | 19.81M | 1.65M | n/a | n/a | n/a | n/a | n/a | 14.89M | 36.21M | 43.4M | 60.53M | 17.5M | n/a | n/a | n/a | n/a | 118.66M | 47.7M | n/a | n/a |
Other Investing Acitivies | -1.1M | -1.09M | -8.39M | -27K | 483.36M | -17.49M | -542K | 444K | 27.66M | 187.88M | -1.05M | 7M | n/a | 178K | -2.43M | n/a | n/a | -35M | n/a | n/a | 24M | -145M |
Investing Cash Flow | 60.29M | 30.66M | -2.84M | -67.23M | 462.64M | -17.49M | -542K | 444K | 27.66M | 202.76M | 35.2M | 50.55M | 41.37M | 17.53M | -129.9M | -457K | -880K | -35.62M | 107.49M | 15.99M | 23.59M | -285.48M |
Debt Repayment | n/a | n/a | n/a | n/a | -233.19M | n/a | -223.41M | 223.27M | -223.27M | n/a | n/a | n/a | n/a | n/a | n/a | 49.49M | n/a | 440K | -672K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -3K | n/a | -264K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.66M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 84K | -60K | 22K | 5K | -48.53M | n/a | 221.94M | -221.98M | 34.71M | -620K | -525K | -332K | -577K | -3.03M | 235K | -701K | -942K | 363K | 469K | -179K | -153K | -1.89M |
Financial Cash Flow | 53.73M | 53.59M | 8.08M | 2K | -281.52M | -264K | 231K | -167K | -187.93M | 887K | 366K | 11.11M | 54.33M | 3.8M | 6.59M | 48.87M | 721K | -1.86M | 1.49M | 1.1M | 46.85M | 2.44M |
Net Cash Flow | -5.96M | 26.36M | -14.47M | -113.54M | 134.48M | -43.58M | 28.3M | -61.74M | -100.53M | 156.88M | 22.18M | 7.35M | 56.78M | -47.4M | -223.26M | 11.32M | -50.2M | -91.52M | 56.66M | 30.8M | 70.25M | -281.67M |
Free Cash Flow | -119.98M | -57.89M | -19.72M | -46.34M | -46.63M | -25.83M | 28.61M | -62.02M | 59.73M | -46.77M | -12.97M | -54.3M | -39.02M | -68.88M | -100.04M | -37.55M | -50.92M | -54.66M | -52.79M | 13.45M | -603K | 1.22M |
Adj. Free Cash Flow | -124.94M | -60.27M | -30.51M | -49.73M | -52.05M | -31.2M | 22.22M | -68.88M | 59.73M | -54.09M | -23.77M | -64.25M | -49.09M | -81.17M | -111.77M | -49.83M | -64.77M | -67.54M | -52.79M | 1.51M | -12.2M | -15.66M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -152K | -87K | -457K | -880K | -615K | -468K | -261K | -415K | -145K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -119.98M | -57.89M | -19.72M | -46.34M | -46.63M | -25.83M | 28.61M | -62.02M | 59.73M | -46.77M | -12.94M | -54.3M | -39.02M | -68.88M | -100.04M | -37.55M | -50.92M | -54.66M | -52.79M | 13.45M | -603K | 1.22M |
Add to Watchlist
Select watchlists to add or remove CHRS